Literature DB >> 23200869

Biofilm formation on coated silicone tympanostomy tubes.

Carolyn P Ojano-Dirain1, Rodrigo C Silva, Patrick J Antonelli.   

Abstract

OBJECTIVES: Tympanostomy tube (TT) surface modifications have been promoted as a means of reducing biofilm formation, otorrhea, and occlusion. The goal of this study was to determine if biofilm formation on silicone TTs could be prevented by commercially available surface coatings.
METHODS: Silicone TTs with and without polyvinylpyrrolidone (PVP) or/and silver oxide were exposed to human plasma and cultured with Pseudomonas aeruginosa or Staphylococcus aureus (22 TTs per group). After 4 days, antibiotics were added to kill planktonic bacteria. Biofilm formation was assessed by quantitative bacterial counts and scanning electron microscopy.
RESULTS: PVP, silver, and PVP-silver coatings reduced P. aeruginosa biofilm formation relative to silicone by over 1 log (p<0.0001). PVP was superior to silver (p=0.04) and PVP-silver (p<0.0001). PVP and PVP-silver coatings increased S. aureus biofilm formation nominally (p=0.01 &amp; 0.003).
CONCLUSION: PVP and silver coatings reduce P. aeruginosa biofilm formation on silicone TTs. Combining PVP and silver coatings does not further improve biofilm resistance. TT surface coatings warrant further study through clinical trials.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23200869     DOI: 10.1016/j.ijporl.2012.10.027

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  2 in total

1.  The rationale for preventive treatments for early post-tympanostomy tube otorrhea in persistent otitis media with effusion.

Authors:  Mohammad Faramarzi; Sareh Roosta; Mahmood Shishegar; Rohollah Abbasi; Saeid Atighechi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-08       Impact factor: 2.503

Review 2.  New paradigms in the pathogenesis of otitis media in children.

Authors:  James Mark Coticchia; Michael Chen; Livjot Sachdeva; Sean Mutchnick
Journal:  Front Pediatr       Date:  2013-12-23       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.